TCG Crossover Management »

Nektar Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.0M 4.0M 1.24
2024-03-31 $3.7M 4.0M 0.93

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Abivax SA Adrs (ABVX)
Silence Therapeutics Adrs (SLN)
Cogent Biosciences Comm (COGT)
Savara Comm (SVRA)
Madrigal Pharmaceuticals Comm (MDGL)
Edgewise Therapeutics Comm (EWTX)
Keros Therapeutics Comm (KROS)
Mineralys Therapeutics Comm (MLYS)
Ocular Therapeutix Comm (OCUL)
Tyra Biosciences Comm (TYRA)
Kura Oncology Comm (KURA)
Structure Therapeutics Adrs (GPCR)
Centessa Pharmaceuticals Comm (CNTA)

View all positions for TCG Crossover Management

Top funds holding Nektar Therapeutics

Deep Track Capital
BlackRock
Vanguard Group
Samlyn Capital
Eventide Asset Management
Citadel Advisors
PRIMECAP Management Company
Acadian Asset Management
Millennium Management
Geode Capital Management
Nantahala Capital Management
TCG Crossover Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics